miR-498/DNMT3b Axis Mediates Resistance to Radiotherapy in Esophageal Cancer Cells
Published 2021 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
miR-498/DNMT3b Axis Mediates Resistance to Radiotherapy in Esophageal Cancer Cells
Authors
Keywords
-
Journal
CANCER BIOTHERAPY AND RADIOPHARMACEUTICALS
Volume -, Issue -, Pages -
Publisher
Mary Ann Liebert Inc
Online
2021-04-22
DOI
10.1089/cbr.2020.4227
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Induction of DNMT3B by PGE2 and IL6 at distant metastatic sites promotes epigenetic modification and breast cancer colonization
- (2020) Li Yang et al. CANCER RESEARCH
- Up-regulation of miR-498 inhibits cell proliferation, invasion and migration of hepatocellular carcinoma by targeting FOXO3
- (2019) Wenqin Li et al. Clinics and Research in Hepatology and Gastroenterology
- Downregulated lncRNA UCA1 acts as ceRNA to adsorb microRNA-498 to repress proliferation, invasion and epithelial mesenchymal transition of esophageal cancer cells by decreasing ZEB2 expression
- (2019) Peng Wang et al. CELL CYCLE
- Surgical treatment of esophageal cancer in the era of multimodality management
- (2018) Alicia S. Borggreve et al. Annals of the New York Academy of Sciences
- Future Perspectives of Surgery for Esophageal Cancer
- (2018) Hirotoshi Kikuchi et al. Annals of Thoracic and Cardiovascular Surgery
- MiR-502 mediates esophageal cancer cell TE1 proliferation by promoting AKT phosphorylation
- (2018) Jing Xu et al. BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS
- Inhibition of DNMT suppresses the stemness of colorectal cancer cells through down-regulating Wnt signaling pathway
- (2018) Shanxin Li et al. CELLULAR SIGNALLING
- Specific or not specific recruitment of DNMTs for DNA methylation, an epigenetic dilemma
- (2018) Eric Hervouet et al. Clinical Epigenetics
- Knockdown of C1GalT1 inhibits radioresistance of human esophageal cancer cells through modifying β1-integrin glycosylation
- (2018) Chuanyi Zhang et al. Journal of Cancer
- Evaluation of the effect of TIM-3 suppression by miR-498 and its effect on apoptosis and proliferation rate of HL-60 cell line
- (2018) Yaser Moghaddam et al. PATHOLOGY RESEARCH AND PRACTICE
- X-ray irradiation induced Disabled-2 gene promoter de-methylation enhances radiosensitivity of non-small-cell lung carcinoma cells
- (2018) Shuang Ma et al. JOURNAL OF EXPERIMENTAL & CLINICAL CANCER RESEARCH
- MiR-498 in esophageal squamous cell carcinoma: clinicopathological impacts and functional interactions
- (2017) Farhadul Islam et al. HUMAN PATHOLOGY
- MicroRNA-377 suppresses initiation and progression of esophageal cancer by inhibiting CD133 and VEGF
- (2017) B Li et al. ONCOGENE
- MicroRNA-375 suppresses esophageal cancer cell growth and invasion by repressing metadherin expression
- (2017) Changmei Hu et al. Oncology Letters
- MiR-338-5p enhances the radiosensitivity of esophageal squamous cell carcinoma by inducing apoptosis through targeting survivin
- (2017) Misun Park et al. Scientific Reports
- MicroRNA-21 promotes cell proliferation, migration, and resistance to apoptosis through PTEN/PI3K/AKT signaling pathway in esophageal cancer
- (2016) Yan-Ran Wu et al. TUMOR BIOLOGY
- TGF-β1 epigenetically modifies Thy-1 expression in primary lung fibroblasts
- (2015) Wendy A. Neveu et al. AMERICAN JOURNAL OF PHYSIOLOGY-CELL PHYSIOLOGY
- A feedback regulation between miR-145 and DNA methyltransferase 3b in prostate cancer cell and their responses to irradiation
- (2015) Gang Xue et al. CANCER LETTERS
- DNMT (DNA methyltransferase) inhibitors radiosensitize human cancer cells by suppressing DNA repair activity
- (2012) Hak Jae Kim et al. Radiation Oncology
- The role of DNA methyltransferase 3b in esophageal squamous cell carcinoma
- (2011) Miao-Fen Chen et al. CANCER
Discover Peeref hubs
Discuss science. Find collaborators. Network.
Join a conversationPublish scientific posters with Peeref
Peeref publishes scientific posters from all research disciplines. Our Diamond Open Access policy means free access to content and no publication fees for authors.
Learn More